Hemostatic Disorders: Clinical Trials

8 trials for Hemostatic Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 18Terminated 8

Follow Hemostatic Disorders: new trials by email Literature Review of Hemostatic Disorders trials Research Report on Hemostatic Disorders

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
64Cu-LLP2A for Imaging Hematologic Malignancies
64Cu-LLP2A, PET/CT - Multiple Myeloma, Low-Grade Lymphoma
Early Phase 1TerminatedWashington University School of Medicine212025-03-202026-10-16
Coagulation and Fibrinolysis of Estradiol in Transwomen
Estradiol Tablets, Transdermal patch - Transgenderism, Clotting Disorder
Early Phase 1TerminatedMedical College of Wisconsin62021-12-072022-12-21
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Allogeneic Hematopoietic Stem Cell Transplantation, Irradiated Allogeneic Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia in Remission
Early Phase 1TerminatedRutgers, The State University of New Jersey22020-10-262023-06-26
64Cu-LLP2A for Imaging Multiple Myeloma
64Cu-LLP2A, PET/MR, Blood samples for serum stability - Multiple Myeloma
Early Phase 1TerminatedWashington University School of Medicine102018-11-202024-11-12
Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma
Blinatumomab - Multiple Myeloma
Early Phase 1TerminatedAbramson Cancer Center at Penn Medicine62017-05-272020-02-07
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Filgrastim, Bortezomib, Carfilzomib - Multiple Myeloma
Early Phase 1TerminatedWashington University School of Medicine72012-06-012015-01-26
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Simvastatin - Cavernous Angioma, Familial, Cerebral Cavernous Malformations
Early Phase 1TerminatedUniversity of New Mexico122012-03-012024-03-12
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
recombinant interferon-α, recombinant interleukin-6 - Multiple Myeloma and Plasma Cell Neoplasm
Early Phase 1TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins32007-10-012018-11-16

Narrower conditions

Multiple Myeloma (6)  ·  Lymphoma, Non-Hodgkin (2)  ·  Chromosome 17 deletion (1)  ·  Hemangioma, Cavernous, Central Nervous System (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, T-Cell (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm, Residual (1)  ·  Neoplasms, Plasma Cell (1)

Broader conditions

Cardiovascular Diseases (8)  ·  Hematologic Diseases (8)  ·  Hemic and Lymphatic Diseases (8)  ·  Hemorrhagic Disorders (8)  ·  Vascular Diseases (8)  ·  Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Blood Protein Disorders (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Lymphoproliferative Disorders (6)  ·  Paraproteinemias (6)  ·  Neoplasms, Plasma Cell (5)  ·  Leukemia (2)

Interventions

Positron Emission Tomography Computed Tomography (2)  ·  Blood Specimen Collection (1)  ·  Bortezomib (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Estradiol (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Interleukin-6 (1)  ·  Lenalidomide (1)  ·  Simvastatin (1)  ·  Thalidomide (1)  ·  Transdermal Patch (1)  ·  blinatumomab (1)  ·  carfilzomib (1)

Sponsors

Washington University School of Medicine (3)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Medical College of Wisconsin (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  University of New Mexico (1)

Countries

United States (8)

Top investigators

Farrokh Dehdashti, M.D. (2)  ·  Alfred Garfall, MD (1)  ·  Blaine Hart, MD (1)  ·  Carol A Huff, MD (1)  ·  Jenna Sarvaideo, DO (1)  ·  Leslie A Morrison, MD (1)  ·  Ravi Vij, M.D. (1)  ·  Roger Strair (1)

NIH funding

P01CA015396 (1), P30CA006973 (1), P30CA072720 (1), R42CA257797 (1), U54NS065705 (1)